Class information for:
Level 1: SMALL CELL LUNG CANCER//AMRUBICIN//PROPHYLACTIC CRANIAL IRRADIATION

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1519 2528 31.4 65%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1835 5652 SMALL CELL LUNG CANCER//BOMBESIN//GASTRIN RELEASING PEPTIDE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SMALL CELL LUNG CANCER Author keyword 309 36% 27% 695
2 AMRUBICIN Author keyword 102 72% 3% 79
3 PROPHYLACTIC CRANIAL IRRADIATION Author keyword 40 47% 2% 63
4 EXTENSIVE STAGE Author keyword 39 80% 1% 24
5 LIMITED DISEASE Author keyword 36 71% 1% 29
6 LIMITED STAGE Author keyword 29 63% 1% 30
7 LIMITED STAGE SMALL CELL LUNG CANCER Author keyword 25 77% 1% 17
8 EXTENSIVE DISEASE Author keyword 25 75% 1% 18
9 SENSITIVE RELAPSE Author keyword 21 90% 0% 9
10 AMRUBICINOL Author keyword 21 85% 0% 11

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 SMALL CELL LUNG CANCER 309 36% 27% 695 Search SMALL+CELL+LUNG+CANCER Search SMALL+CELL+LUNG+CANCER
2 AMRUBICIN 102 72% 3% 79 Search AMRUBICIN Search AMRUBICIN
3 PROPHYLACTIC CRANIAL IRRADIATION 40 47% 2% 63 Search PROPHYLACTIC+CRANIAL+IRRADIATION Search PROPHYLACTIC+CRANIAL+IRRADIATION
4 EXTENSIVE STAGE 39 80% 1% 24 Search EXTENSIVE+STAGE Search EXTENSIVE+STAGE
5 LIMITED DISEASE 36 71% 1% 29 Search LIMITED+DISEASE Search LIMITED+DISEASE
6 LIMITED STAGE 29 63% 1% 30 Search LIMITED+STAGE Search LIMITED+STAGE
7 LIMITED STAGE SMALL CELL LUNG CANCER 25 77% 1% 17 Search LIMITED+STAGE+SMALL+CELL+LUNG+CANCER Search LIMITED+STAGE+SMALL+CELL+LUNG+CANCER
8 EXTENSIVE DISEASE 25 75% 1% 18 Search EXTENSIVE+DISEASE Search EXTENSIVE+DISEASE
9 SENSITIVE RELAPSE 21 90% 0% 9 Search SENSITIVE+RELAPSE Search SENSITIVE+RELAPSE
10 AMRUBICINOL 21 85% 0% 11 Search AMRUBICINOL Search AMRUBICINOL

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 9 AMINOANTHRACYCLINE 135 97% 1% 37
2 CROSS RESISTANT CHEMOTHERAPY 122 79% 3% 77
3 THORACIC RADIOTHERAPY 99 38% 8% 206
4 CISPLATIN PLUS ETOPOSIDE 86 84% 2% 47
5 PROPHYLACTIC CRANIAL IRRADIATION 81 35% 7% 189
6 ANTHRACYCLINE DERIVATIVE SM 5887 61 95% 1% 20
7 ETOPOSIDE CISPLATIN 58 68% 2% 52
8 RESEARCH CAMPAIGN TRIAL 48 91% 1% 20
9 DAILY THORACIC RADIOTHERAPY 46 82% 1% 27
10 SM 5887 45 94% 1% 16

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Management of Small Cell Lung Cancer Recent Developments for Optimal Care 2012 25 88 77%
Treatment of patients with small-cell lung cancer: From meta-analyses to clinical practice 2013 13 34 91%
Small cell lung cancer 2008 97 104 54%
Small-cell lung cancer 2005 218 136 49%
Small Cell Lung Cancer: Therapies and Targets 2014 5 85 72%
Small cell lung cancer 2003 68 71 92%
Chemotherapy advances in small-cell lung cancer 2013 9 84 81%
A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis 2000 93 45 87%
Treatment options for small cell lung cancer - do we have more choice? 2010 28 73 84%
Chemotherapy for small cell lung cancer 2003 63 58 88%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SOTIRIA HOSP ATHENS 4 75% 0.1% 3
2 LUNG THORAC TUMORS 2 67% 0.1% 2
3 MED ONCOL B171 2 67% 0.1% 2
4 THORA SURG 2 67% 0.1% 2
5 INTERNAL MED THORAC ONCOL 2 16% 0.4% 10
6 PULM DIS 1 1 31% 0.2% 4
7 MIDDLESEX HOSP MED ONCOL 1 50% 0.1% 2
8 SECT BIOMED STAT INFORMAT 1 100% 0.1% 2
9 THORAC MALIGNANCY 1 13% 0.4% 9
10 PULM DIS 2 1 30% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000106224 ETOPOSIDE PHOSPHATE//ETOPOSIDE//ORAL ETOPOSIDE
2 0.0000097272 SMALL CELL LUNG CANCER CELL LINE//SMALL CELL LUNG CANCER CELL LINES//DRUG SCREENING ASSAY
3 0.0000075701 VINORELBINE//GEMCITABINE//ADVANCED NON SMALL CELL LUNG CANCER
4 0.0000068021 LARGE CELL NEUROENDOCRINE CARCINOMA//TYPICAL CARCINOID//ATYPICAL CARCINOID
5 0.0000064139 STAGE III//LOCALLY ADVANCED NON SMALL CELL LUNG CANCER//ACUTE ESOPHAGITIS
6 0.0000057655 EXOCERVIX//MUCOSAL LEUKOCYTES//IMMUNOBIOL CELL DIFFERENTIAT UNIT
7 0.0000056367 INMUNOFERON//GLYCOPHOSPHOPEPTICAL//AM3
8 0.0000050450 EXTRAPULMONARY SMALL CELL CARCINOMA//SMALL CELL CARCINOMA//SMALL CELL CARCINOMA OF THE ESOPHAGUS
9 0.0000045930 CYFRA 21 1//CYTOKERATIN 19 FRAGMENTS//PROGRP
10 0.0000040910 BRAIN METASTASES//WHOLE BRAIN RADIOTHERAPY//WHOLE BRAIN RADIATION THERAPY